4/A//SEC Filing
CONWAY ROBERT E 4/A
Accession 0001626199-21-000130
CIK 0001626199other
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 7:02 AM ET
Size
5.8 KB
Accession
0001626199-21-000130
Insider Transaction Report
Form 4/AAmended
CONWAY ROBERT
Director
Transactions
- Purchase
Common Stock
2021-09-23$10.08/sh+15,000$151,154→ 50,000 total(indirect: By Trust)
Footnotes (2)
- [F1]The Form 4 filed on September 24, 2021 inadvertently included an incorrect transaction code for the reported transaction. The transaction code included on the original Form 4 was "S" while the correct transaction code should have been "P".
- [F2]This transaction was executed in multiple trades at prices ranging from $9.945 to $10.20. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
ALPINE IMMUNE SCIENCES, INC.
CIK 0001626199
Entity typeother
Related Parties
1- filerCIK 0001184334
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 7:02 AM ET
- Size
- 5.8 KB